The Latest

Promo Image

This Week in HIV Research: This Is Your Brain on Stigma

The impact of stigma on cognitive performance; risk factor dissonance among young black MSM; pregnancy and the HIV care continuum; new data on pediatric raltegravir use.

Donna Futterman, M.D. and Rachel L. Epstein, M.D., M.A.

Too Few Teens and Youth Adults Using Opioids Are Screened for Hepatitis C and HIV, New Study Finds

Despite their increased risk, only one-third of adolescents and young adults with known opioid use disorder were screened for hepatitis C, according to a study released at the IDWeek conference in San Francisco.

Younger People Living With HIV More Likely to Have a Positive Self Image Img

Younger People Living With HIV More Likely to Have a Positive Self Image

Results from a survey of people living with HIV in the UK who are aged 15-24 included the optimistic results that younger people might be experiencing less stigma than older HIV-positive people.

Promo Image

Once-Daily Option for Pediatric Use of Prezista

On 1 February 2013, the FDA approved revisions to the darunavir (Prezista) tablet and oral suspension label to include paediatric use.

This included once daily dosing in treatment-naive subjects 3 to less than 18 years of age and once-daily dosing i...

Promo Image

High Rates of HSV-2 Infection in HIV-Positive Teens in United States

Rates of herpes simplex virus type 2 (HSV-2) infection were much higher in teens with HIV or with a high risk of HIV than in the general population, according to results of a large study at 15 centers across the United States.1 HSV-2 prevalence, the ...

Promo Image

FDA Approve Pediatric Dose for Darunavir

On December 16, 2011, The Food and Drug Administration approved an oral suspension formulation of darunavir (Prezista). Darunavir is now available as a 100 mg/mL oral suspension.

Additionally, the product labeling was updated to provide dosing recom...

Promo Image

Nominations for New Physician/Clinician Members of the DHHS Panel on Pediatric Antiretroviral Therapy and Management Guidelines

The Department of Health and Human Services (HHS) Panel on Pediatric Antiretroviral Therapy and Management Guidelines (the Pediatric Guidelines Panel) is accepting nominations for new members with clinical research and/or practice expertise in manage...

Promo Image

New Guidance on Prevention of Mother-to-Child Transmission of HIV and Infant Feeding in the Context of HIV

2010 Guidelines: "Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infections in Infants"

Since WHO issued revised guidelines in 2006, important new evidence has emerged on the use of antiretroviral (ARV) prophylaxis for the pre...

Promo Image

U.S. Updates Clinical Guidelines for Prevention and Treatment of Opportunistic Infections Among HIV-Exposed and HIV-Infected Children

New guidelines to assist health care workers in preventing and treating the secondary infections that can afflict U.S. children exposed to, or infected with, HIV, were published by the National Institutes of Health and the Centers for Disease Control...

Promo Image

FDA Approves Pediatric Dosing for Ritonavir

On October 6, 2005, the Food and Drug Administration approved dosing recommendations for Norvir (ritonavir) in pediatric patients one month to two years of age. The major revisions to the package insert include the following:

Clinical Pharmacology